Jane M. Bynum
GlaxoSmithKline (United States) · 13 works · 890 citations · h-index 9
Top works
- Structural Analyses Reveal Phosphatidyl Inositols as Ligands for the NR5 Orphan Receptors SF-1 and LRH-1
- Immunobiology of primary intracranial tumors
- Crystallization of protein–ligand complexes
- Primary antibody response to keyhole limpet hemocyanin in rat as a model for immunotoxicity evaluation
- Monoclonal antibody specific for the T-tubule of skeletal muscle.
- Structure of Rev-erbα bound to N-CoR reveals a unique mechanism of nuclear receptor–co-repressor interaction
- Improved biodistribution, tumor targeting, and reduced immunogenicity in mice with a gamma 4 variant of Campath-1H.
- Expression, Purification, and Characterization of the Human Receptor Activator of NF-κB Ligand (RANKL) Extracellular Domain
- Development of Class-Switched, Affinity-Matured Monoclonal Antibodies Following a 7-Day Immunization Schedule
- human Steroidogenic Factor 1 LBD with bound Co-factor Peptide
- Production and characterization of mouse monoclonal antibodies against S-100 protein
- Mouse SF-1 LBD
- Generation of Murine Monoclonal Antihuman Milk Fat Globule Membrane Antibodies Using Immunoprecipitation and BIAcore™ Analyses